Bare Stent    Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents Catheter Cardiovasc Interv (2008) 71; 594-8 C. Whan Lee, S. H. Kim, J. Suh, D. W. Park, S. H. Lee, Y. H. Kim, M. K. Hong, J. J. Kim, S. W. Park and S. J. Park Survival advantage in Medicare patients receiving drug-eluting stents compared with bare metal stents: real or artefactual? Catheter Cardiovasc Interv (2008) 71; 636-43 F. W. Wang, B. F. Uretsky, J. L. Freeman, D. Zhang, S. H. Giordano and J. S. Goodwin Long-term outcomes with drug-eluting stents versus bare metal stents in the treatment of saphenous vein graft disease (results from the REgistro Regionale AngiopLastiche Emilia-Romagna registry) Am J Cardiol (2008) 101; 947-52 L. Vignali, F. Saia, A. Manari, A. Santarelli, A. Rubboli, E. Varani, G. Piovaccari, A. Menozzi, G. Percoco, A. Benassi, G. Rusticali, P. Marzaroli, P. Guastaroba, R. Grilli, A. Maresta and A. Marzocchi Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION! Intervention Study J Am Coll Cardiol (2008) 51; 618-26 B. L. van der Hoeven, S. S. Liem, J. W. Jukema, N. Suraphakdee, H. Putter, J. Dijkstra, D. E. Atsma, M. Bootsma, K. Zeppenfeld, P. V. Oemrawsingh, E. E. van der Wall and M. J. Schalij Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents J Am Coll Cardiol (2008) 51; 1925-34 D. Trenk, W. Hochholzer, M. F. Fromm, L. E. Chialda, A. Pahl, C. M. Valina, C. Stratz, P. Schmiebusch, H. P. Bestehorn, H. J. Buttner and F. J. Neumann Comparison of drug-eluting stents and bare-metal stents for the treatment of unprotected left main coronary artery disease in acute coronary syndromes Am J Cardiol (2009) 103; 187-93 C. Tamburino, M. E. Di Salvo, D. Capodanno, T. Palmerini, I. Sheiban, M. Margheri, G. Vecchi, G. Sangiorgi, G. Piovaccari, A. Bartorelli, C. Briguori, D. Ardissino, F. Di Pede, A. Ramondo, L. Inglese, A. S. Petronio, L. Bolognese, A. Benassi, C. Palmieri, V. Filippone and S. De Servi Are drug-eluting stents superior to bare-metal stents in patients with unprotected non-bifurcational left main disease? Insights from a multicentre registry Eur Heart J (2009) C. Tamburino, M. E. Di Salvo, D. Capodanno, A. Marzocchi, I. Sheiban, M. Margheri, A. Maresta, F. Barlocco, G. Sangiorgi, G. Piovaccari, A. Bartorelli, C. Briguori, D. Ardissino, F. Di Pede, A. Ramondo, L. Inglese, A. S. Petronio, L. Bolognese, A. Benassi, C. Palmieri, A. Patti and S. De Servi Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents Am J Cardiol (2009) 103; 491-5 D. H. Steinberg, M. A. Gaglia, Jr., T. L. Pinto Slottow, P. Roy, L. Bonello, A. De Labriolle, G. Lemesle, R. Torguson, K. Kineshige, Z. Xue, W. O. Suddath, K. M. Kent, L. F. Satler, A. D. Pichard, J. Lindsay and R. Waksman Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events Eur Heart J (2009) 30; 321-9 P. G. Steg, K. A. Fox, K. A. Eagle, M. Furman, F. Van de Werf, G. Montalescot, S. G. Goodman, A. Avezum, W. Huang and J. M. Gore Long-term impact of drug-eluting stents versus bare-metal stents on all-cause mortality J Am Coll Cardiol (2008) 52; 1041-8 M. H. Shishehbor, S. S. Goel, S. R. Kapadia, D. L. Bhatt, P. Kelly, R. E. Raymond, J. M. Galla, S. J. Brener, P. L. Whitlow and S. G. Ellis Temporal changes in coronary revascularization procedures, outcomes, and costs in the bare-metal stent and drug-eluting stent eras: results from the US Medicare program Circulation (2009) 119; 952-61 J. Ryan, W. Linde-Zwirble, L. Engelhart, L. Cooper and D. J. Cohen Long-term benefit-risk balance of drug-eluting vs. bare-metal stents in daily practice: does stent diameter matter? Three-year follow-up of BASKET Eur Heart J (2009) 30; 16-24 M. Pfisterer, H. P. Brunner-La Rocca, P. Rickenbacher, P. Hunziker, C. Mueller, F. Nietlispach, G. Leibundgut, F. Bader and C. Kaiser The balance of risks and benefits of drug-eluting versus bare-metal stents J Am Coll Cardiol (2008) 51; 972; author reply 72-3 M. Pfisterer, H. P. Brunner-La Rocca and C. Kaiser Drug-eluting or bare-metal stents for large coronary vessel stenting? The BASKET-PROVE (PROspective Validation Examination) trial: study protocol and design Am Heart J (2008) 155; 609-14 M. Pfisterer, O. Bertel, P. O. Bonetti, H. P. Brunner-La Rocca, F. R. Eberli, P. Erne, S. Galatius, B. Hornig, W. Kiowski, O. Pachinger, G. Pedrazzini, H. Rickli, S. De Servi and C. Kaiser Meta-analysis comparison (nine trials) of outcomes with drug-eluting stents versus bare metal stents in patients with diabetes mellitus Am J Cardiol (2008) 102; 1328-34 G. Patti, A. Nusca and G. Di Sciascio Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study) Am J Cardiol (2009) 103; 181-6 M. R. Patel, M. E. Pfisterer, A. Betriu, P. Widmisky, D. R. Holmes, Jr., W. W. O'Neill, A. Stebbins, F. Van de Werf, P. W. Armstrong and C. B. Granger Two-year clinical outcome with drug-eluting stents versus bare-metal stents in a real-world registry of unprotected left main coronary artery stenosis from the Italian Society of Invasive Cardiology Am J Cardiol (2008) 102; 1463-8 T. Palmerini, A. Marzocchi, C. Tamburino, I. Sheiban, M. Margheri, G. Vecchi, G. Sangiorgi, A. Santarelli, A. Bartorelli, C. Briguori, L. Vignali, F. Di Pede, A. Ramondo, L. Inglese, M. De Carlo, L. Bolognese, A. Benassi, C. Palmieri, V. Filippone, D. Sangiorgi and S. De Servi Drug-eluting stents versus bare metal stents for narrowing in saphenous vein grafts Am J Cardiol (2008) 102; 530-4 T. Okabe, J. Lindsay, A. N. Buch, D. H. Steinberg, P. Roy, T. L. Slottow, K. Smith, R. Torguson, Z. Xue, L. F. Satler, K. M. Kent, A. D. Pichard, N. J. Weissman and R. Waksman Optimal treatment for in-stent restenosis after BMS--DES, coated balloon, or scalpel? Eur Heart J (2008) 29; 1595-6 D. Mukherjee Long-term clinical outcomes after drug-eluting and bare-metal stenting in Massachusetts Circulation (2008) 118; 1817-27 L. Mauri, T. S. Silbaugh, R. E. Wolf, K. Zelevinsky, A. Lovett, Z. Zhou, F. S. Resnic and S. L. Normand Comparison of effectiveness and safety of sirolimus-eluting stents versus bare-metal stents in patients with diabetes mellitus (from the Italian Multicenter Randomized DESSERT Study) Am J Cardiol (2008) 101; 1560-6 A. Maresta, E. Varani, M. Balducelli, F. Varbella, C. Lettieri, L. Uguccioni, P. Sangiorgio and G. B. Zoccai Comparison of stent thrombosis, myocardial infarction, and mortality following drug-eluting versus bare-metal stent coronary intervention in patients with diabetes mellitus Am J Cardiol (2008) 102; 165-72 M. Maeng, L. O. Jensen, A. Kaltoft, H. H. Hansen, M. Bottcher, J. F. Lassen, P. Thayssen, L. R. Krusell, K. Rasmussen, L. Pedersen, H. T. Sorensen, S. P. Johnsen and L. Thuesen Usefulness of serum cathepsin L as an independent biomarker in patients with coronary heart disease Am J Cardiol (2009) 103; 476-81 Y. Liu, X. Li, D. Peng, Z. Tan, H. Liu, Y. Qing, Y. Xue and G. P. Shi An integrated TAXUS IV, V, and VI intravascular ultrasound analysis of the predictors of edge restenosis after bare metal or paclitaxel-eluting stents Am J Cardiol (2009) 103; 501-6 J. Liu, A. Maehara, G. S. Mintz, N. J. Weissman, A. Yu, H. Wang, L. Mandinov, J. J. Popma, S. G. Ellis, E. Grube, K. D. Dawkins and G. W. Stone Sirolimus-eluting stents, bare metal stents or coronary artery bypass grafting for patients with multivessel disease including involvement of the proximal left anterior descending artery: analysis of the Arterial Revascularization Therapies study part 2 (ARTS-II) Heart (2009) N. Kukreja, P. W. Serruys, B. de Bruyne, A. Colombo, C. Macaya, G. Richardt, J. Fajadet, C. Hamm, D. Goedhart, N. Macours and H. P. Stoll Three-year survival following multivessel percutaneous coronary intervention with bare-metal or drug-eluting stents in unselected patients Am J Cardiol (2009) 103; 203-11 N. Kukreja, Y. Onuma, H. M. Garcia-Garcia, J. Daemen, R. van Domburg and P. W. Serruys Long-term outcomes of coronary-artery bypass graft surgery versus percutaneous coronary intervention for multivessel coronary artery disease in the bare-metal stent era Circulation (2008) 118; S199-209 T. Kimura, T. Morimoto, Y. Furukawa, Y. Nakagawa, S. Shizuta, N. Ehara, R. Taniguchi, T. Doi, K. Nishiyama, N. Ozasa, N. Saito, K. Hoshino, H. Mitsuoka, M. Abe, M. Toma, T. Tamura, Y. Haruna, Y. Imai, S. Teramukai, M. Fukushima and T. Kita Meta-analysis of the effects of paclitaxel-eluting stents versus bare metal stents on volumetric intravascular ultrasound in patients with versus without diabetes mellitus Am J Cardiol (2008) 101; 1263-8 M. Kimura, G. S. Mintz, N. J. Weissman, K. D. Dawkins, E. Grube, S. G. Ellis, L. A. Cannon, Z. Masud, L. Mandinov, D. Baim and G. W. Stone Are "treatment" bare metal stents superior to "control" bare metal stents? A meta-analytic approach Am Heart J (2008) 155; 624-9, 29 e1-2 D. M. Kent and T. A. Trikalinos Drug-eluting versus bare metal stents in patients with st-segment-elevation myocardial infarction: eight-month follow-up in the Drug Elution and Distal Protection in Acute Myocardial Infarction (DEDICATION) trial Circulation (2008) 118; 1155-62 H. Kelbaek, L. Thuesen, S. Helqvist, P. Clemmensen, L. Klovgaard, A. Kaltoft, B. Andersen, H. Thuesen, T. Engstrom, H. E. Botker, K. Saunamaki, L. R. Krusell, E. Jorgensen, H. H. Hansen, E. H. Christiansen, J. Ravkilde, L. Kober, K. F. Kofoed, C. J. Terkelsen and J. F. Lassen 2-year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry) J Am Coll Cardiol (2009) 53; 658-64 A. Kaltoft, L. O. Jensen, M. Maeng, H. H. Tilsted, P. Thayssen, M. Bottcher, J. F. Lassen, L. R. Krusell, K. Rasmussen, K. N. Hansen, L. Pedersen, S. P. Johnsen, H. T. Sorensen and L. Thuesen Sleep quality and elevated blood pressure in adolescents Circulation (2008) 118; 1034-40 S. Javaheri, A. Storfer-Isser, C. L. Rosen and S. Redline Neointimal regression-induced incomplete coverage of a bare-metal stent in the left main trunk: Serial angiographic and angioscopic evidence obtained by 5-year follow-up Catheter Cardiovasc Interv (2008) M. Ichikawa and M. Mishima Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis Eur Heart J (2009) A. K. Hassan, S. C. Bergheanu, T. Stijnen, B. L. van der Hoeven, J. D. Snoep, J. W. Plevier, M. J. Schalij and J. W. Jukema Comparison of long-term efficacy of the paclitaxel-eluting stent versus the bare-metal stent for treatment of unprotected left main coronary artery disease Am J Cardiol (2009) 103; 194-8 Y. Han, S. Wang, Q. Jing, Y. Li, H. Liu, Y. Ma, Z. Wang, D. Wang, B. Luan, G. Wang and T. Chen The impact of lesion length and vessel size on outcomes after sirolimus-eluting stent implantation for in-stent restenosis Heart (2008) 94; 1162-5 S. Habara, K. Mitsudo, T. Goto, K. Kadota, S. Fujii, H. Yamamoto, H. Kato, S. Takenaka, Y. Fuku, S. Hosogi, A. Hirono, K. Yamamoto, H. Tanaka, D. Hasegawa, Y. Nakamura, H. Tasaka, S. Otsuru, Y. Okamoto, C. Yamada, M. Miyamoto and K. Inoue Drug-eluting compared with bare-metal coronary stents among elderly patients J Am Coll Cardiol (2008) 51; 2017-24 P. W. Groeneveld, M. A. Matta, A. P. Greenhut and F. Yang 10-year follow-up of a prospective randomized trial comparing bare-metal stenting with internal mammary artery grafting for proximal, isolated de novo left anterior coronary artery stenosis the SIMA (Stenting versus Internal Mammary Artery grafting) trial J Am Coll Cardiol (2008) 52; 815-7 J. J. Goy, U. Kaufmann, M. Hurni, S. Cook, F. Versaci, P. Ruchat, O. Bertel, M. Pieper, B. Meier, L. Chiarello and E. Eeckhout Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts Catheter Cardiovasc Interv (2008) 72; 13-20 G. Gioia, A. Benassi, R. Mohendra, K. Chowdhury, I. Masood and W. Matthai Drug-eluting or bare-metal stenting in patients with diabetes mellitus: results from the Massachusetts Data Analysis Center Registry Circulation (2008) 118; 2277-85, 7p following 85 P. Garg, S. L. Normand, T. S. Silbaugh, R. E. Wolf, K. Zelevinsky, A. Lovett, M. R. Varma, Z. Zhou and L. Mauri Balancing the risks of restenosis and stent thrombosis in bare-metal versus drug-eluting stents: results of a decision analytic model J Am Coll Cardiol (2008) 51; 1844-53 P. Garg, D. J. Cohen, T. Gaziano and L. Mauri Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go Eur Heart J (2008) 29; 609-17 K. A. Eagle, B. K. Nallamothu, R. H. Mehta, C. B. Granger, P. G. Steg, F. Van de Werf, J. Lopez-Sendon, S. G. Goodman, A. Quill and K. A. Fox Angiographic and clinical outcomes of drug-eluting versus bare metal stent deployment in the Occluded Artery Trial Catheter Cardiovasc Interv (2008) V. Dzavik, C. E. Buller, G. Devlin, R. G. Carere, G. B. Mancini, W. J. Cantor, P. E. Buszman, J. M. Rankin, C. Vozzi, J. R. Ross, S. Forman, B. A. Barton, A. G. Lamas and J. S. Hochman A randomized comparison of sirolimus-eluting versus bare metal stents in the treatment of diabetic patients with native coronary artery lesions: the DECODE study Catheter Cardiovasc Interv (2008) 72; 591-600 C. Chan, R. Zambahari, U. Kaul, C. P. Lau, H. Whitworth, S. Cohen and M. Buchbinder Long-term clinical benefit of drug-eluting stents over bare-metal stents in diabetic patients with de novo left main coronary artery disease: results from a real-world multicenter registry Catheter Cardiovasc Interv (2009) 73; 310-6 D. Capodanno, M. E. Di Salvo, T. Palmerini, I. Sheiban, M. Margheri, G. Vecchi, G. Sangiorgi, G. Piovaccari, A. Bartorelli, C. Briguori, D. Ardissino, F. Di Pede, A. Ramondo, L. Inglese, A. S. Petronio, L. Bolognese, A. Benassi, C. Palmieri, V. Filippone, S. De Servi and C. Tamburino Angiographic and clinical outcome of invasively managed patients with thrombosed coronary bare metal or drug-eluting stents: the OPTIMIST study Eur Heart J (2008) 29; 3011-21 F. Burzotta, A. Parma, C. Pristipino, A. Manzoli, F. Belloni, G. Sardella, S. Rigattieri, A. Danesi, P. Mazzarotto, F. Summaria, E. Romagnoli, F. Prati, C. Trani and F. Crea Outcomes with drug-eluting stents versus bare metal stents in acute ST-elevation myocardial infarction: results from the Strategic Transcatheter Evaluation of New Therapies (STENT) Group Catheter Cardiovasc Interv (2008) 72; 893-900 B. R. Brodie, T. Stuckey, W. Downey, A. Humphrey, M. Nussbaum, S. Laurent, B. Bradshaw, C. Metzger, J. Hermiller, F. Krainin, S. Juk, B. Cheek, P. Duffy and C. A. Simonton A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions the SOS (Stenting of Saphenous Vein Grafts) trial J Am Coll Cardiol (2009) 53; 919-28 E. S. Brilakis, C. Lichtenwalter, J. A. de Lemos, M. Roesle, O. Obel, D. Haagen, B. Saeed, C. Gadiparthi, J. K. Bissett, R. Sachdeva, V. V. Voudris, P. Karyofillis, B. Kar, J. Rossen, P. Fasseas, P. Berger and S. Banerjee Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries Am J Cardiol (2009) 103; 496-500 L. Bonello, A. De Labriolle, G. Lemesle, P. Roy, D. H. Steinberg, T. L. Slottow, Z. Xue, R. Torguson, K. Kaneshige, W. O. Suddath, L. F. Satler, K. M. Kent, J. Lindsay, A. D. Pichard and R. Waksman Incidence of coronary stent thrombosis based on academic research consortium definitions Am J Cardiol (2008) 102; 683-8 R. J. Applegate, M. T. Sacrinty, W. C. Little, R. M. Santos, S. K. Gandhi and M. A. Kutcher "Off-label" stent therapy 2-year comparison of drug-eluting versus bare-metal stents J Am Coll Cardiol (2008) 51; 607-14 R. J. Applegate, M. T. Sacrinty, M. A. Kutcher, R. M. Santos, S. K. Gandhi, T. T. Baki and W. C. Little Late outcomes of drug-eluting versus bare metal stents in saphenous vein grafts: Propensity score analysis Catheter Cardiovasc Interv (2008) 72; 7-12 R. J. Applegate, M. Sacrinty, M. Kutcher, R. Santos, S. Gandhi and W. Little Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial Circulation (2009) 119; 687-98 J. Aoki, A. J. Lansky, R. Mehran, J. Moses, M. E. Bertrand, B. T. McLaurin, D. A. Cox, A. M. Lincoff, E. M. Ohman, H. D. White, H. Parise, M. B. Leon and G. W. Stone Sirolimus-eluting stents versus bare-metal stents in patients with in-stent restenosis: results of a pooled analysis of two randomized studies Catheter Cardiovasc Interv (2008) 72; 459-67 F. Alfonso, M. J. Perez-Vizcayno, R. Hernandez, C. Fernandez, J. Escaned, C. Banuelos, A. Bethencourt, J. R. Lopez-Minguez, J. Angel, A. Cequier, M. Sabate, C. Moris, J. Zueco and R. Seabra-Gomes